Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown250%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Screening for Hearing Loss After Childhood Cancer

NCT06036407
completednot_applicable

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

NCT06381297
unknown

Study of Diagnostic Biomarkers of Acute Acoustic Trauma

NCT04832230
unknown

Maternal Diabetes in Newborns With Hearing Loss

NCT05152589

Clinical Trials (4)

Showing 4 of 4 trials
NCT06036407Not Applicable

Screening for Hearing Loss After Childhood Cancer

Completed
NCT06381297Not Applicable

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

Completed
NCT04832230

Study of Diagnostic Biomarkers of Acute Acoustic Trauma

Unknown
NCT05152589

Maternal Diabetes in Newborns With Hearing Loss

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4